Field JK - Search Results

1

Guilty by dissociation: Part A: Development of a rapid Ultra-High Performance Liquid Chromatography (UHPLC)-MS/MS methodology for the analysis of regioisomeric diphenidine-derived Novel Psychoactive Substances (NPS).

Field JK, Hinz C, Titman CM, Hulme MC, Cowan RM, Ainsworth-McMillan JB, Gilbert N, Lee RJ, Marron J, Costello A, Mewis RE, Euerby MR, Sutcliffe OB. Field JK, et al. J Pharm Biomed Anal. 2022 Jul 15;216:114798. doi: 10.1016/j.jpba.2022.114798. Epub 2022 Apr 26. J Pharm Biomed Anal. 2022. PMID: 35561436 Free article.

2

Guilty by dissociation: Part B: evaluation of Supercritical Fluid Chromatography (SFC-UV) for the analysis of regioisomeric diphenidine-derived Novel Psychoactive Substances (NPS).

Cochrane G, Field JK, Hulme MC, Gilbert N, Mewis RE, Euerby MR, Sutcliffe OB. Cochrane G, et al. Among authors: field jk. J Pharm Biomed Anal. 2022 Jul 15;216:114797. doi: 10.1016/j.jpba.2022.114797. Epub 2022 Apr 26. J Pharm Biomed Anal. 2022. PMID: 35550280 Free article.

3

Investigation into reversed phase chromatography peptide separation systems part II: An evaluation of the robustness of a protocol for column characterisation.

Field JK, Euerby MR, Petersson P. Field JK, et al. J Chromatogr A. 2019 Oct 11;1603:102-112. doi: 10.1016/j.chroma.2019.05.037. Epub 2019 May 23. J Chromatogr A. 2019. PMID: 31182305 Free article.

4

Investigation into reversed phase chromatography peptide separation systems part III: Establishing a column characterisation database.

Field JK, Euerby MR, Petersson P. Field JK, et al. J Chromatogr A. 2020 Jul 5;1622:461093. doi: 10.1016/j.chroma.2020.461093. Epub 2020 Apr 13. J Chromatogr A. 2020. PMID: 32340726 Free article.

5

Investigation into reversed-phase chromatography peptide separation systems Part IV: Characterisation of mobile phase selectivity differences.

Field JK, Euerby MR, Haselmann KF, Petersson P. Field JK, et al. J Chromatogr A. 2021 Mar 29;1641:461986. doi: 10.1016/j.chroma.2021.461986. Epub 2021 Feb 9. J Chromatogr A. 2021. PMID: 33631703 Free article.

6

Investigation into reversed-phase chromatography peptide separation systems part V: Establishment of a screening strategy for development of methods for assessment of pharmaceutical peptides' purity.

Cheung MY, Bruce J, Euerby MR, Field JK, Petersson P. Cheung MY, et al. Among authors: field jk. J Chromatogr A. 2022 Apr 12;1668:462888. doi: 10.1016/j.chroma.2022.462888. Epub 2022 Feb 8. J Chromatogr A. 2022. PMID: 35231862

7

Investigation into reversed phase chromatography peptide separation systems part I: Development of a protocol for column characterisation.

Field JK, Euerby MR, Lau J, Thøgersen H, Petersson P. Field JK, et al. J Chromatogr A. 2019 Oct 11;1603:113-129. doi: 10.1016/j.chroma.2019.05.038. Epub 2019 May 23. J Chromatogr A. 2019. PMID: 31262515 Free article.

8

Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.

Davies MPA, Vulkan D, Gabe R, Duffy SW, Field JK. Davies MPA, et al. Among authors: field jk. Lancet Reg Health Eur. 2024 May 20;42:100936. doi: 10.1016/j.lanepe.2024.100936. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 38813535 Free PMC article.

9

Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification.

Wang X, Zhang Z, Ding Y, Chen T, Mucci L, Albanes D, Landi MT, Caporaso NE, Lam S, Tardon A, Chen C, Bojesen SE, Johansson M, Risch A, Bickeböller H, Wichmann HE, Rennert G, Arnold S, Brennan P, McKay JD, Field JK, Shete SS, Le Marchand L, Liu G, Andrew AS, Kiemeney LA, Zienolddiny-Narui S, Behndig A, Johansson M, Cox A, Lazarus P, Schabath MB, Aldrich MC, Hung RJ, Amos CI, Lin X, Christiani DC. Wang X, et al. Among authors: field jk. Genome Med. 2024 Feb 5;16(1):22. doi: 10.1186/s13073-024-01298-4. Genome Med. 2024. PMID: 38317189 Free PMC article.

10

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.

Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, Murphy N, Burrows K, Bouras E, Smith-Byrne K, Lewis SJ, Galesloot TE, Kiemeney LA, Vermeulen S, Martin P, Albanes D, Hou L, Newcomb PA, White E, Wolk A, Wu AH, Le Marchand L, Phipps AI, Buchanan DD; International Lung Cancer Consortium; PRACTICAL Consortium; Zhao SS, Gill D, Chanock SJ, Purdue MP, Davey Smith G, Brennan P, Herzig KH, Järvelin MR, Amos CI, Hung RJ, Dehghan A, Johansson M, Gunter MJ, Tsilidis KK, Martin RM. Yarmolinsky J, et al. EBioMedicine. 2024 Feb;100:104991. doi: 10.1016/j.ebiom.2024.104991. Epub 2024 Feb 1. EBioMedicine. 2024. PMID: 38301482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page